Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ludovica F. S. Grasso, Renata S. Auriemma, Rosario Pivonello & Annamaria Colao. (2017) Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegaly. Expert Review of Endocrinology & Metabolism 12:1, pages 73-85.
Read now
Read now
Cynthia Plunkett & Ariel L Barkan. (2015) The care continuum in acromegaly: how patients, nurses, and physicians can collaborate for successful treatment experiences. Patient Preference and Adherence 9, pages 1093-1099.
Read now
Read now
Ludovica FS Grasso, Renata S Auriemma, Rosario Pivonello & Annamaria Colao. (2015) Adverse events associated with somatostatin analogs in acromegaly. Expert Opinion on Drug Safety 14:8, pages 1213-1226.
Read now
Read now
Seung Rim Hwang & Youngro Byun. (2014) Advances in oral macromolecular drug delivery. Expert Opinion on Drug Delivery 11:12, pages 1955-1967.
Read now
Read now
Andrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, Vito Amoroso & Alfredo Berruti. (2014) Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. Expert Opinion on Investigational Drugs 23:12, pages 1619-1635.
Read now
Read now
Guo-Wei Wang, Jiang-Jiang Qin, Xiang-Rong Cheng, Yun-Heng Shen, Lei Shan, Hui-Zi Jin & Wei-Dong Zhang. (2014)
Inula sesquiterpenoids: structural diversity, cytotoxicity and anti-tumor activity. Expert Opinion on Investigational Drugs 23:3, pages 317-345.
Read now
Read now
Articles from other publishers (6)
Sahil Butala, Vasanti Suvarna, Rashmi Mallya & Tabassum Khan. (2021) An insight into cytotoxic activity of flavonoids and sesquiterpenoids from selected plants of Asteraceae species. Chemical Biology & Drug Design 98:6, pages 1116-1130.
Crossref
Crossref
Sylvia L. Asa & Shereen Ezzat. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Claudia Pivonello, Panagoula Rousaki, Mariarosaria Negri, Maddalena Sarnataro, Maria Napolitano, Federica Zito Marino, Roberta Patalano, Maria Cristina De Martino, Concetta Sciammarella, Antongiulio Faggiano, Gaetano Rocco, Renato Franco, Gregory A. Kaltsas, Annamaria Colao & Rosario Pivonello. (2016) Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study. Endocrine 56:3, pages 603-620.
Crossref
Crossref
Rosario Pivonello, Renata S. Auriemma, Ludovica F. S. Grasso, Claudia Pivonello, Chiara Simeoli, Roberta Patalano, Mariano Galdiero & Annamaria Colao. (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20:1, pages 46-62.
Crossref
Crossref
L. Duan, M. Huang, H. Yan, Y. Zhang & F. Gu. (2015) Cost-effectiveness analysis of two therapeutic schemes in the treatment of acromegaly: a retrospective study of 168 cases. Journal of Endocrinological Investigation 38:7, pages 717-723.
Crossref
Crossref
P. Terranova. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.